Interestingly, in both patients with MS + CIS and SC + RIS, we found a marked downregulation of expression of all the measured surface markers on the nonclassical monocytes compared with intermediate or classical, except for CD40 and TACE, where the intermediate monocytes have higher expression. This evidence concerns the gene ADAM17 and in situ carcinoma.